Snap Chart
How Medtechs Are Rerouting Supply Chains for Resilience
In the face of continued tariff uncertainty, most medtech companies are getting ready to take action.
Auteurs
Amanda Adler
Associé, New York
Scott Daubin
Associé, New York
First published in mai 2025